Quick Yielding Modified Short-Distance Fenestration Technique for the Treatment of Complex Aortic Arch Diseases: a Multicenter Single-Arm Objective Performance Criteria Trial(QYM-Tech Study)
NCT06639243 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 87
Last updated 2024-10-15
Summary
Background: This study investigates the safety and efficacy of a novel surgical approach combining thoracic endovascular aortic repair (TEVAR) and in situ fenestration reconstruction of supra-aortic branches using the Quick Yielding Modified (QYM) technique. This procedure aims to address complex aortic arch diseases, providing an alternative to more invasive open surgical interventions.
Methods: This is a prospective, multicenter, single-arm, interventional study involving 87 patients across 3 centers. Eligible participants are adults aged 18-80 diagnosed with thoracic aortic dissection, thoracic aortic aneurysm (true or pseudo), penetrating aortic ulcer, or intramural hematoma, necessitating supra-aortic branch vessel reconstruction. The surgical protocol involves TEVAR combined with the QYM technique for fenestration and revascularization.
Primary Outcome: The primary endpoint is the incidence of major adverse events (MAE) within 30 days post-operation.
Secondary Outcomes: Secondary endpoints include 12-month aortic treatment success, all-cause mortality, aortic-related mortality, incidence of severe adverse events, occurrence of Type I/III endoleaks, stent graft migration, patency of revascularized branches, and rates of conversion to open surgery or reintervention due to aortic complications.
Inclusion/Exclusion Criteria: Key inclusion criteria include imaging-confirmed thoracic aortic disease requiring endovascular repair with a proximal landing zone in the aortic arch (Zone 0) and suitable anatomical features for stent placement. Patients with recent systemic infections, severe coronary artery involvement, or other significant comorbidities were excluded.
Follow-up and Statistical Analysis: Patients will undergo follow-ups at discharge, 30 days, 6 months, and 12 months post-surgery. Statistical analyses will include descriptive statistics of quantitative and categorical variables, with statistical significance set at a one-sided p-value \< 0.025.
This study aims to provide critical insights into the clinical applicability of the QYM technique, potentially broadening therapeutic options for complex aortic arch diseases.
Conditions
- Thoracic Aortic Dissection
- Thoracic Aortic Aneurysm (true Aneurysm)
- Thoracic Pseudoaneurysm
- Penetrating Aortic Ulcer
- Intramural Hematoma of the Thoracic Aorta
Interventions
- DEVICE
-
QYM Technique
The intervention in this study involves the application of the Quick Yielding Modified (QYM) technique for the treatment of complex aortic arch diseases. This procedure consists of two main components: 1. Thoracic Endovascular Aortic Repair (TEVAR): This minimally invasive procedure utilizes a covered stent graft to exclude the diseased segment of the thoracic aorta, providing immediate protection against rupture and controlling blood flow. 2. In Situ Fenestration and Revascularization of Supra-Aortic Branches: Following TEVAR, the QYM technique includes creating fenestrations in the stent graft to allow for the revascularization of the supra-aortic branches (such as the brachiocephalic, left common carotid, and left subclavian arteries). This is achieved through direct puncture and reconstruction of the branch vessels, ensuring adequate blood flow to these critical arteries while preserving their function. The combination of these techniques aims to achieve effective treatment out
Sponsors & Collaborators
-
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-01
- Primary Completion
- 2028-12-31
- Completion
- 2028-12-31
- FDA Device
- Yes
Countries
- China
Study Locations
More Related Trials
-
Conventional Versus Mini-Sternotomy for Aortic Valve Surgery
NCT00221663 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Reconstruction of Diffusely Diseased Left Anterior Descending with Left Internal Mammary Artery On-lay Patch or Saphenous Vein Patch Without Endarterectomy by Opening the Whole Wall of the Diseased Segment(s) Has Less Risk and Fewer Complications Compared to Endarterectomy Technique
NCT06835114 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of Transcatheter Aortic Valve Replacement With A² Flex and Commissural Alignment Technology in Severe Aortic Stenosis
NCT06721676 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Mitral Valve Repair Combined Coronary Artery Bypass Grafting(CABG) Verus CABG Alone on Functional Ischemic Mitral Regurgitation
NCT03525041 ·Status: UNKNOWN ·Phase: NA
-
Minimally Invasive Transthoracic Device Closure in Perimembranous Ventricular Septal Defect
NCT02644330 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Hybrid Operation in Thoracic Aortic Dissection
NCT01500395 ·Status: UNKNOWN
-
Arch-Clamping Technique Under Mild Hypothermia in Treating With Acute Type A Aortic Dissection
NCT07150559 ·Status: RECRUITING ·Phase: NA
-
Virtual Histology Intravascular Ultrasound to Evaluate Prognostic Risks of Saphenous Vein Graft Disease Before Percutaneous Coronary Intervention.
NCT03175952 ·Status: UNKNOWN
-
Application of Vascular Closure Device in Transvenous Cardiac Intervention
NCT05521100 ·Status: UNKNOWN ·Phase: NA
-
Modified Aortic Root Enlargement Procedure
NCT06517537 ·Status: RECRUITING
-
Comparison of One-stop Hybrid Revascularization Versus Percutaneous Coronary Intervention for the Treatment of Multi-vessel Disease
NCT01035034 ·Status: UNKNOWN ·Phase: NA
-
Transapical Beating-Heart Septal Myectomy for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
NCT05648825 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Real-World Prospective Parallel Controlled Study on Endovascular Therapy for Improving Perfusion and Remodeling of TBAD
NCT07022145 ·Status: NOT_YET_RECRUITING
-
Evaluate Safety and Effectiveness of XenoSure Biological Patch in the Application of Cardiac Repair
NCT03176225 ·Status: COMPLETED ·Phase: NA
-
Effect of Remote Ischemia Preconditioning on Myocardial Injury in Patients Undergoing Heart Valve Surgery
NCT01175681 ·Status: COMPLETED ·Phase: NA
-
Triple-branch Stent Graft Placement and Total-arch Replacement for the Treatment of Acute DeBakey I Aortic Dissection
NCT02622750 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Angioplasty Guidewire-Assisted Versus Conventional Transseptal Puncture for Left Atrial Appendage Occlusion
NCT05125159 ·Status: UNKNOWN ·Phase: NA
-
Quantitative Flow Ratio (QFR) Guided Coronary Artery Bypass Grafting for Patients Undergoing Primary Valve Surgery With Concomitant Coronary Artery Disease
NCT03977129 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Swartz Sheath With Angioplasty Guidewire-Assisted Technique for Patent Foramen Ovale Closure (STAGE-PFO)
NCT06793969 ·Status: RECRUITING ·Phase: NA
-
Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function (STICH 3.0-NL)
NCT07269366 ·Status: RECRUITING ·Phase: NA
-
Multicenter Study Evaluating the Efficacy of an Intervention Aimed At Reducing the Length of Stay After Transfemoral Transcatheter Aortic Valve Implantation
NCT04503655 ·Status: COMPLETED ·Phase: NA
-
Antegrade Cerebral Perfusion and Retrograde Inferior Vena Caval Perfusion for Total Aortic Arch Replacement
NCT03607786 ·Status: UNKNOWN ·Phase: NA
-
Vascular Complications and Bleeding After Transfemoral TAVI
NCT03865043 ·Status: COMPLETED
-
Safety and Efficacy of XJ-Procedure in Patients With Acute Type A Aortic Dissection Surgery
NCT06199401 ·Status: RECRUITING ·Phase: NA
-
Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses and Anatomic Isthmuses in Repaired Tetralogy of Fallot
NCT05236153 ·Status: UNKNOWN ·Phase: NA